HIV–1 neutralizing antibodies: How full is the bottle?
- 1 February 1999
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 5 (2) , 142-144
- https://doi.org/10.1038/5502
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Neutralizing antibody directed against the HIV–1 envelope glycoprotein can completely block HIV–1/SIV chimeric virus infections of macaque monkeysNature Medicine, 1999
- Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell–free virions from blood plasmaNature Medicine, 1999
- Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteersAIDS, 1998
- Neutralization of Syncytium‐Inducing Primary Isolates by Sera from Human Immunodeficiency Virus (HIV)–Uninfected Recipients of Candidate HIV VaccinesThe Journal of Infectious Diseases, 1998
- Progress in the Development of an HIV-1 VaccineScience, 1998
- Why do we not have an HIV vaccine and how can we make one?Nature Medicine, 1998
- Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1Nature Medicine, 1997
- Neutralizing and Infection-Enhancing Antibody Responses to Human Immunodeficiency Virus Type 1 in Long-Term NonprogressorsThe Journal of Infectious Diseases, 1996
- Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer.The Journal of Experimental Medicine, 1995
- Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibodyNature, 1992